Published in J Infect Dis on April 01, 1972
Vaccines and cell-mediated immunity. Bacteriol Rev (1974) 5.42
Isolation of Vi antigen and a simple method for its measurement. Appl Microbiol (1972) 2.20
Vaccination against typhoid fever: present status. Bull World Health Organ (1994) 1.52
Vi antigen from Salmonella typhosa and immunity against typhoid fever. I. Isolation and immunologic properties in animals. Infect Immun (1974) 1.08
Vi antigen from Salmonella typhosa and immunity against typhoid fever. 11. Safety and antigenicity in humans. Infect Immun (1975) 1.02
Constitutive expression of the Vi polysaccharide capsular antigen in attenuated Salmonella enterica serovar typhi oral vaccine strain CVD 909. Infect Immun (2000) 0.99
Ineffectiveness of Vi and chemically treated endotoxins as typhoid vaccines in mice challenged with a Salmonella typhosa-Salmonella typhimurium hybrid. Infect Immun (1975) 0.93
Determination of endotoxicity in bacterial vaccines. Appl Microbiol (1973) 0.90
Evaluation of two Salmonella typhimurium hybrids as challenge organisms in a system for the assay of typhoid vaccines. Infect Immun (1982) 0.75
Effect of glass on pH-dependent stability of typhoid vaccine. J Clin Microbiol (1976) 0.75
Charcoal-yeast extract agar: primary isolation medium for Legionella pneumophila. J Clin Microbiol (1979) 15.15
Primary isolation media for Legionnaires disease bacterium. J Clin Microbiol (1978) 11.86
Pittsburgh pneumonia agent: direct isolation from human lung tissue. J Infect Dis (1980) 11.36
Plasmid-mediated tissue invasiveness in Yersinia enterocolitica. Nature (1980) 8.15
Isolation of the Legionnaires' disease bacterium from environmental samples. Ann Intern Med (1979) 7.69
Cholera--a possible endemic focus in the United States. N Engl J Med (1980) 6.71
Travelers' diarrhea in Mexico. A prospective study of physicians and family members attending a congress. N Engl J Med (1976) 6.52
Epidemic Yersinia enterocolitica infection due to contaminated chocolate milk. N Engl J Med (1978) 5.39
Detection of antibodies to legionnaires disease organism by microagglutination and micro-enzyme-linked immunosorbent assay tests. J Clin Microbiol (1978) 4.45
The Pyrogenicity of Bacterial Contaminants Found in Biologic Products. J Bacteriol (1945) 4.39
Legionella gormanii sp. nov. J Clin Microbiol (1980) 4.12
Site and characteristics of electrolyte loss and effect of intraluminal glucose in experimental canine cholera. J Clin Invest (1968) 3.72
A case of cholera in Texas, 1973. Am J Epidemiol (1974) 3.71
Laboratory investigation of diarrhea in travelers to Mexico: evaluation of methods for detecting enterotoxigenic Echerichia coli. J Clin Microbiol (1976) 3.34
Pertussis toxin: the cause of the harmful effects and prolonged immunity of whooping cough. A hypothesis. Rev Infect Dis (1980) 3.34
Water-related nosocomial pneumonia caused by Legionella pneumophila serogroups 1 and 10. J Infect Dis (1985) 3.16
Evidence for two distinct types of penicillinase-producing Neisseria gonorrhoeae. Lancet (1977) 3.09
Proliferation of Legionella pneumophila as an intracellular parasite of the ciliated protozoan Tetrahymena pyriformis. Appl Environ Microbiol (1984) 3.02
"Endotoxicity" of the Legionnaires' disease bacterium. Ann Intern Med (1979) 2.78
Immunochemical, serologic, and immunologic properties of major antigens isolated from the Legionnaires' disease bacterium. Observations bearing on the feasibility of a vaccine. Ann Intern Med (1979) 2.76
Detection of Legionella pneumonophila antigen in urine by enzyme-linked immunospecific assay. J Clin Microbiol (1979) 2.54
Isolation of protozoa from water associated with a legionellosis outbreak and demonstration of intracellular multiplication of Legionella pneumophila. Appl Environ Microbiol (1986) 2.52
Cholera on Guam, 1974: epidemiologic findings and isolation of non-toxinogenic strains. Am J Epidemiol (1977) 2.46
The concept of pertussis as a toxin-mediated disease. Pediatr Infect Dis (1984) 2.45
Epidemiologic study of a fatal case of inhalation anthrax. Arch Environ Health (1969) 2.39
Evaluation of the microenzyme-linked immunosorbent assay with Treponema pallidum antigen. J Clin Microbiol (1982) 2.35
Virulence and phenotypic characterization of Yersinia enterocolitica isolated from humans in the United States. J Clin Microbiol (1983) 2.32
Comparison of guinea pig and protozoan models for determining virulence of Legionella species. Infect Immun (1986) 2.28
Antibiotic treatment of guinea-pigs infected with agent of Legionnaires' disease. Lancet (1978) 2.28
Possible nosocomial transmission of group B streptococci in a newborn nursery. J Pediatr (1975) 2.21
Isolation of Vi antigen and a simple method for its measurement. Appl Microbiol (1972) 2.20
Identification of problem Neisseria gonorrhoeae cultures by standard and experimental tests. J Clin Microbiol (1982) 2.17
A major focus of Legionnaires' disease in Bloomington, Indiana. Ann Intern Med (1979) 2.16
Standardization and control of meningococcal vaccines, group A and group C polysaccharides. J Biol Stand (1977) 2.11
A simultaneous outbreak of meningococcal and influenza infections. N Engl J Med (1972) 2.11
Susceptibility of Pittsburgh pneumonia agent (Legionella micdadei) and other newly recognized members of the genus Legionella to nineteen antimicrobial agents. Antimicrob Agents Chemother (1981) 2.10
Titration of cholera antitoxin levels by passive hemagglutination tests using fresh and formalinized sheep erythrocytes. Proc Soc Exp Biol Med (1970) 2.10
Characteristics of non-cholera Vibrios isolated from cases of human diarrhoea. Bull World Health Organ (1965) 2.09
Immunization against neonatal tetanus in New Guinea. Antitoxin response of pregnant women to adjuvant and plain toxoids. Bull World Health Organ (1965) 2.05
Isolation of Listeria monocytogenes from raw milk. Appl Environ Microbiol (1986) 2.04
Tuberculin sensitivity testing and treatment of latent tuberculosis remains effective for tuberculosis control in human immunodeficiency virus-infected patients in Hong Kong. Hong Kong Med J (2013) 2.02
Report of the 1966-67 cholera vaccine field trial in rural East Pakistan. I. Study design and results of the first year of observation. Bull World Health Organ (1969) 2.00
Evaluation of a new assay for Vi antibody in chronic carriers of Salmonella typhi. J Clin Microbiol (1980) 1.90
Biochemistry of Vibrio cholerae Virulence I. Purification and Biochemical Properties of PF/Cholera Enterotoxin. Infect Immun (1970) 1.87
Multiple serotypes of vibrio cholerae isolated from a case of cholera. Evidence suggesting in-vivo mutation. Lancet (1967) 1.83
Cyclophosphamide in the treatment of systemic lupus erythematosus. Br Med J (1966) 1.83
Bordetella pertussis respiratory tract infection in the mouse: pathophysiological responses. J Infect Dis (1980) 1.82
Pontiac fever: isolation of the etiologic agent (Legionella pneumophilia) and demonstration of its mode of transmission. Am J Epidemiol (1981) 1.77
Tetanus and diphtheria immunity in an elderly population in Los Angeles County. Am J Public Health (1983) 1.77
Sodium desoxycholate-extracted treponemal antigen in an enzyme-linked immunosorbent assay for syphilis. J Clin Microbiol (1982) 1.75
Toluidine red unheated serum test, a nontreponemal test for syphilis. J Clin Microbiol (1983) 1.74
Lyme disease: a selective medium for isolation of the suspected etiological agent, a spirochete. J Clin Microbiol (1984) 1.72
Trans-isolate medium: a new medium for primary culturing and transport of Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae. J Clin Microbiol (1984) 1.70
Human disease caused by Brucella canis. A clinical and epidemiologic study of two cases. JAMA (1975) 1.69
Universal decline in mortality in patients with advanced HIV-1 disease in various demographic subpopulations after the introduction of HAART in Hong Kong, from 1993 to 2002. HIV Med (2006) 1.61
Legionellosis. Am J Pathol (1981) 1.59
Immunoglobulin specificity for the fluorescent treponemal antibody-absorption test conjugate. J Clin Microbiol (1976) 1.58
Salmonella excretion by turtles. Public Health Rep (1967) 1.57
Titration of cholera antitoxin in human sera by microhemagglutination with formalinized erythrocytes. Appl Microbiol (1970) 1.55
Enzyme-linked immunosorbent assay for detection of Salmonella typhi Vi antigen in urine from typhoid patients. J Clin Microbiol (1982) 1.55
Nuclease enhancement of specific cell agglutination in a serodiagnostic test for Neisseria gonorrhoeae. J Clin Microbiol (1979) 1.53
Immunologic factors affecting the in-vivo and in-vitro survival of the Legionnaires' disease bacterium. Ann Intern Med (1979) 1.53
Immunization against neonatal tetanus in New Guinea. 3. The toxin-neutralization test and the response of guinea-pigs to the toxoids as used in the immunization schedules in New Guinea. Bull World Health Organ (1970) 1.52
Immunological conversion of Vibrio chorlerae in gnotobiotic mice. Infect Immun (1972) 1.52
Absolute quantification of regional myocardial uptake of 99mTc-sestamibi with SPECT: experimental validation in a porcine model. J Nucl Med (2001) 1.52
Laboratory assays of different types of field trial typhoid vaccines and relationship to efficacy in man. J Bacteriol (1966) 1.50
Urethritis in women attending an STD clinic. Br J Vener Dis (1981) 1.48
Tularemia epidemia: Vermont, 1968. Forty-seven cases linked to contact with muskrats. N Engl J Med (1969) 1.47
Upper limit of normal titer for detection of antibodies to Legionella pneumophila by the microagglutination test. J Clin Microbiol (1979) 1.45
Differences in clinical and laboratory diagnostic characteristics of penicilliosis marneffei in human immunodeficiency virus (HIV)- and non-HIV-infected patients. J Clin Microbiol (2001) 1.44
Immunological and serological diversity of Neisseria gonorrhoeae: immunotyping of gonococci by cross-protein in guinea pig subcutaneous chambers. Infect Immun (1976) 1.42
The microbiology and therapy of acute pelvic inflammatory disease in hospitalized patients. Am J Obstet Gynecol (1980) 1.42
Legionella anisa: a new species of Legionella isolated from potable waters and a cooling tower. Appl Environ Microbiol (1985) 1.41
Vi serology in the detection of typhoid carriers. Lancet (1981) 1.39
Treatment outcomes after early initiation of antiretroviral therapy for human immunodeficiency virus-associated tuberculosis. Hong Kong Med J (2013) 1.39
Antibiotic susceptibility of clinical isolates of Listeria monocytogenes. Antimicrob Agents Chemother (1978) 1.38
Detection of enterotoxigenic and invasive strains of Yersinia enterocolitica. Contrib Microbiol Immunol (1979) 1.38
Isolation of Yersinia enterocolitica from well water and growth in distilled water. Appl Environ Microbiol (1977) 1.38
TREATMENT OF BLACKTONGUE WITH COZYMASE. Science (1938) 1.35
Toxic shock syndrome: modification and comparison of methods for detecting marker proteins in Staphylococcus aureus. J Clin Microbiol (1983) 1.34
The 1968-1969 cholera-vaccine field trial in rural East Pakistan. Effectiveness of monovalent Ogawa and Inaba vaccines and a purified Inaba antigen, with comparative results of serological and animal protection tests. J Infect Dis (1970) 1.34
Cellular lipids of the Legionnaires' disease bacterium. Ann Intern Med (1979) 1.33
Susceptibility of the Lyme disease spirochete to seven antimicrobial agents. Yale J Biol Med (1985) 1.32
Bottle feeding as a risk factor for cholera in infants. Lancet (1979) 1.31
Acquired ability of Staphylococcus aureus to produce toxic shock-associated protein and resulting illness in a rabbit model. Infect Immun (1985) 1.30
Waterborne gastrointestinal illness at a ski resort. --Isolation of Yersinia enterocolitica from drinking water--. Public Health Rep (1977) 1.29
Enzyme-linked immunosorbent assay for detection of human antibodies to Salmonella typhi Vi antigen. J Clin Microbiol (1983) 1.27
Somatic O antigen relationship of Brucella and Vibrio cholerae. J Bacteriol (1969) 1.23
Immunoglobulin specificity of the microagglutination test for the Legionnaires' disease bacterium. Ann Intern Med (1979) 1.23
An evaluation of penicillin prophylaxis during an outbreak of foodborne streptococcal pharyngitis. Am J Epidemiol (1977) 1.22
Genetic probing of Campylobacter jejuni for cholera toxin and Escherichia coli heat-labile enterotoxin. Lancet (1984) 1.21
Yersinia enterocolitica infection in a 4-month-old infant associated with infection in household dogs. J Pediatr (1976) 1.21
Outer membrane protein subtypes and biotypes of Haemophilus influenzae type b: relation between strains isolated in 1934-1954 and 1977-1980. J Infect Dis (1983) 1.20
Anthrax indirect microhemagglutination test. J Immunol (1971) 1.19